A B STRA CT Multiple indices of thyroid hormone binding have been studied in sera obtained from patients with thyrotoxic Graves' disease, before and after treatment, and in sera from a group of carefully matched normal controls. Specimens from patients with thyrotoxicosis displayed a decrease in the thyroxine (T4)-binding capacities of T4-binding globulin (TBG) and T4-binding prealbumin (TBPA), an increase in serum proteinbound iodine (PBI), and an increase in both the proportion and absolute concentration of free T4. In addition, a smaller than normal proportion of 131I-labeled T, was associated with TBG during filter paper electrophoresis. After treatment of thyroxicosis, the only residual abnormality detected was a very slight persistent decrease in the T4-binding capacity of TBPA, which did not appear to influence the overall thyroid hormone-plasma protein interaction significantly, regardless of whether this was assessed under basal conditions or after enrichment of specimens with stable T,. INTRODUCTION There is general agreement that the overall thyroid hormone-plasma protein complex is abnormal in patients with the diffuse toxic goiter of Graves' disease. This abnormality consists of a greater relative saturation of the plasma thyroxine (T4)-binding proteins, which, in turn, results in a greater proportion of the hormone in the blood being present in the free or unbound state (1) (2) (3) . The existence of this abnormality has been repeatedly demonstrated by in vitro techniques, such as red blood cell or resin uptake tests (4) (5) (6) , or by the direct measurement of the proportion of free T4 (1-3). There has been some question, however, concerning the factors which lead to the abnormality of thyroid hormone transport in the plasma of the thyrotoxic patient. Considerable evidence indicates that an increased concentration of hormone is at least partly responsible. In addition, the binding capacity of the T4-binding prealbumin (TBPA) is usually diminished (1, 7, 8) . Evidence as to whether a similar decrease in binding capacity occurs in the case of the T4-binding globulin (TBG) has been more variable (1, (8) (9) (10) (11) (12) (13) (14) (15) (16) .
According to concepts now widely held, the increased proportion of free T4 in the serum should explain, at least in part, the accelerated fractional peripheral turnover of T4 which occurs in thyro-toxic patients; however, the operation of cellular factors, in addition, has not been excluded (9, 11, 17, 18) . Since abnormalities in the peripheral metabolism of T4 have been found to persist in some patients after treatment of thyrotoxicosis (17, 19, 20) , it appeared of interest to determine whether abnormalities in the thyroid hormoneplasma protein interaction might also persist after treatment. Earlier studies of individual indices of thyroid hormone binding have provided no evidence that this is the case (16, 17, 21) ; however, a comprehensive study of this question has not been reported. In the present studies, multiple indices of thyroid hormone binding, including direct measurements of the T4-binding capacities of TBG and TBPA and of free T4, have been applied to the study of sera from patients with diffuse toxic goiter, before and after treatment, and from a group of carefully matched normal controls. The data reveal no residual abnormality in the overall binding of thyroid hormone in the sera of patients with Graves' disease after thyrotoxicosis has been controlled. The proportion of free T4 was measured in duplicate by a method described in this laboratory (2) , with the following modifications. The .3.I-labeled T4 used in this analysis was partially purified by preliminary dialysis, as suggested by Schussler and Plager (22) , and dilute (1: 25) serum, rather than whole serum, was employed.
METHODS
In addition, "'I-labeled T3 2 was added to an aliquot of the five specimens in each set to produce a final concentration of 2 Ag/100 ml; this addition provided approximately 0.8 /Ac of "1I per ml. These specimens were subjected to reverse-flow electrophoresis in the Durrum apparatus with glycine-acetate buffer (pH 8.6), according to a technique described elsewhere (8, 23) .
Samples of serum from thyrotoxic patients, before and after treatment, and from their corresponding controls, were enriched with stable T4 to concentrations of 119 and 476 lug/100 ml for measurement of the T4-binding capacities of TBG and TBPA, respectively. Analyses were conducted both by direct-flow electrophoresis in glycineacetate buffer (pH 8.6), as described earlier from this laboratory (24) , and by the reverse-flow technique. Radioactive analysis of electrophoretic strips was performed by direct counting of radioactive zones localized by radioautography.
For each type of test, all analyses of the samples belonging to each set were conducted concurrently.
Measurements of serum protein-bound iodine (PBI) were made by a modification of the method of Zak (25) . For comparison of values for the various functions studied among the several groups, the "paired t" test was employed; this and other analyses were conducted according to methods described by Snedecor (26) .
RESULTS
The principal results obtained are presented in Tables I and II . For each test, the statistical significance of differences among the several groups of specimens is shown in Table III .
Serum protein-bound iodine (PBI). Values for the PBI averaged 12.9 + 2.5 ug/100 ml (mean ± SD) in specimens from thyrotoxic patients and were significantly lower after treatment, averaging 5.5 + 0.9 jug/100 ml. The mean PBI in the normal controls was 5.3 ± 0.8 ,ug/100 ml, a value significantly lower than in specimens obtained during thyrotoxicosis, but not significantly different from those in the patients with treated thyrotoxicosis.
Thyroxine-binding capacityof TBG. As judged by reverse-flow electrophoresis, the T4-binding Age   T  TT  T TT  T TT  T  TTE TT  T TTE TT  T  TTE TT pg T4/100 ml pg T4/100 ml pg/100 ml mpng T4/100 ml % I Based on measurements made by reverse-flow filter paper electrophoresis in glycine-acetate buffer, pH 8.6 . § N indicates normal control donor. Number indicates the number of the corresponding age and sex-matched patient with Graves' disease in Table I . 25 .0 Mug/100 ml). In the specimens from thyrotoxic patients, however, the T4-binding capacity of TBG, as indicated by conventional electrophoresis, averaged 23.2 ,ug/100 ml, a value significantly higher (P < 0.001) than that found by the reverse-flow technique. Hence, values found by conventional electrophoresis did not differ significantly among the three groups.
Thyroxine-binding capacity of TBPA. From measurements with the reverse-flow technique, the T4-binding capacity of TBPA in normal sera averaged 232 ± 27 jug/100 ml. In sera from patients with active thyrotoxicosis, the corresponding val- ues were uniformly decreased, averaging 137 ± 31 MAg/100 ml (P < 0.001). After treatment, values increased in all patients, reaching a mean of 199 ± 29 ug/100 ml. The latter value was, nevertheless, significantly lower than that found in normal specimens (P < 0.01). Per cent of free T4 in serum. In normal specimens, the per cent of free T4 averaged 0.017 + 0.002.3 Values in patients with active thyrotoxicosis were much higher, averaging 0.031 + 0.005. After treatment of thyrotoxicosis, the per cent of free T4 in serum decreased in all patients. The difference between the mean value in specimens from patients with treated thyrotoxicosis (0.016 + 0.002) and that in normal specimens was of Lorderline statistical significance (P = 0.05).
Enrichment of normal sera with stable T4 increased the value for the per cent of free T4 in all specimens, the mean reaching 0.021 + 0.003. A similar increase occurred consistently upon enrichment of sera from patients with treated thyrotoxicosis. The mean value achieved (0.020 + 0.003) was essentially the same as that found in normal serum upon enrichment with T4. In both groups, values for the per cent of free T4 achieved by enrichment with stable hormone were not nearly as high as those found in the patients with active thyrotoxicosis.
Concentration of free T4 in serum. Values for the absolute concentration of free T4 were calculated only in specimens obtained from patients with thyrotoxicosis, before and after treatment, and from normal controls. In the latter group, the concentration of free T4 averaged 1.37 ± 0.24 mUg/100 ml. Very similar values were obtained in specimens from patients with treated thyrotoxicosis (1.27 + 0.24 mug/100 ml). Values in both groups were far lower than in patients with active thyrotoxicosis, in whom values averaged 6.35 ± 1.90 mtg/100 ml.
Binding of T3 by TBG. The per cent of added labeled T3 associated with TBG averaged 63.3 ± 5.2 in normal specimens. In speciments from patients with treated thyrotoxicosis, values were not significantly different, averaging 65.6 ± 8.9. In contrast, a pronounced decrease in the per cent of added T3 associated with TBG was seen in specimens from patients with active thyrotoxicosis, values averaging 44.0 + 7.9.
Enrichment with stable T4 of both normal specimens and those from patients with treated thyrotoxicosis decreased the per cent of T3 bound by TBG in all subjects in each group. Although a slightly higher percentage (56.7 ± 6.5) was found in sera from patients with treated thyrotoxicosis than in sera from normal controls (53.4 ± 6.1), this difference was not significant. In neither group did specimens enriched with stable T4 display values for the per cent of T3 bound by TBG as low as those seen in. sera from patients with active thyrotoxicosis.
DISCUSSION
The proportion of T4 in serum that is unbound or free is a direct measure of the overall intensity of T4 binding by serum proteins, to which it is inversely related. In the present as in earlier reports (1-3), the per cent of free T4 was found to be increased, often greatly so, in the serum of patients with active thyrotoxicosis. Two general factors seem to cause this increase. That the first factor is an increase in the concentration of T4 in the serum is indicated by the increased proportion of free T4 that occurred when, in this and earlier studies (2), normal sera were enriched with stable T4 to concentrations equal to those present in thyrotoxicosis. Nevertheless, an increase in the concentration of T4 cannot be the sole factor, since values for the per cent of free T4 as large as those found in thyrotoxicosis did not result. Therefore, a second factor must be invoked, and this would appear to be a decrease in the level or capacity of the T4-binding proteins, TBG and TBPA. Several studies have revealed a decrease in the T4-binding capacity of TBPA in the serum of thyrotoxic patients, similar to that found in the present studies (1, 7, 8) . Available data concerning the T4-binding capacity of TBG in thyrotoxicosis have been more variable, however (1, (8) (9) (10) (11) (12) (13) (14) (15) (16) . Possible reasons for these discrepancies will be discussed below. However, the slight decrease in the T4-binding capacity of TBG noted in the present studies is similar to that reported by Inada and Sterling, who used similar electrophoretic techThyroxine Transport in Treated Thyrotoxicosis niques (8) . Furthermore, we have demonstrated that when thyrotoxicosis is treated, the T4-binding capacity of TBG in the serum of individual patients almost invariably increases. This observation strongly suggests that the T4-binding capacity had previously been depressed.
It is not certain how much the increased per cent of free T4 in the sera of thyrotoxic patients results from a decrease in the T4-binding activity of TBG and how much from the decrease in TBPA. In previous studies from this laboratory, it was shown that small or moderate increments in the concentration of stable T4 increased the per cent of free T4 only slightly (a finding confirmed in the present studies), unless T4 binding by TBPA was diminished (2) . Viewed in another light, the same findings indicate that a decrease in T4 binding by TBPA has only a small effect on the per cent of free T4, unless the concentration of stable T4 is increased. Additional studies to be published separately also indicate that only a small increase in the proportion of free T4 is produced when TBPA is removed from normal serum by specific immunoadsorption (27) . When, however, the relative saturation of TBG is increased by either enrichment of specimens with T4 or by a primary reduction in TBG binding sites, removal of TBPA results in a large increase in the per cent of free T4. In the serum of thyrotoxic patients, the relative saturation of TBG is indeed increased, owing to both a decrease in TBG binding sites and an increase in the total concentration of T,. Hence, in sera of thyrotoxic patients, for any prevailing concentration of T4, the decrease in the T4-binding capacity of TBG increases the importance of a decrease in the binding capacity of TBPA.
Several factors may explain the discrepant data in the literature concerning the changes which occur in the T4-binding capacity of TBG in the serum of patients with thyrotoxicosis. First, it seems possible that the extent of decrease in TBG depends on the severity or duration of the disease; this factor is difficult to evaluate from the present or previous data. Failure to detect a lowering of TBG in thyrotoxicosis also may have resulted from differences in the preponderant sex or age of the patients in the thyrotoxic and control groups, since the binding capacity of TBG has been shown to vary significantly with these factors (24, 28) . Finally, the present studies strongly indicate that small decreases in the T4-binding capacity of TBG may be obscured when the binding capacity of TBPA is also reduced if conventional, rather than reverse-flow, electrophoresis is employed. In normal sera and in those obtained from patients after treatment of thyrotoxicosis, in both of which TBPA was essentially normal, no significant difference between values for the T4-binding capacity of TBG assessed by the two electrophoretic techniques was found. In sera from thyrotoxic patients, however, in which the binding capacity of TBPA was subnormal, higher values were found by conventional than by reverse-flow electrophoresis, and by the former technique no difference between normal specimens and those from thyrotoxic patients was detected. It seems likely that this phenomenon can be ascribed to trailing of albumin-bound T4 across the TBG zone during conventional electrophoresis. This possibility, originally suggested by Robbins, first prompted development of the reverse-flow technique (29) . In sera containing little TBPA, a greater proportion of labeled T4 is associated with albumin than is the case in sera in which TBPA is normal, particularly at the high concentrations of stable T4 used to measure the binding capacity of TBG. Hence, during conventional electrophoresis of sera in which the binding of T4 by TBPA is decreased, trailing of albumin becomes a significant factor in producing a spuriously high value for the binding capacity of TBG. In some previous studies which indicated that no decrease in the binding capacity of TBG occurs during thyrotoxicosis, conventional electrophoresis was employed (1, 11) .
The major objective of the present study was to ascertain whether any abnormalities in the thy roid hormone-plasma protein interaction which were present during active thyrotoxicosis would persist after restoration of a euthyroid state. Previous studies have provided suggestive evidence bearing upon this point. In a group of patients showing persistent abnormalities in T4 turnover, no abnormality in TBG could be detected (17) .
Schussler, who estimates the T4-binding capacity of TBG indirectly, has reported an increase to follow treatment of thyrotoxic patients with propylthiouracil (16). Mitchell, Bradford, and Collins found that the per cent of 131I-labeled T, associated with TBG during electrophoresis, which is decreased during active thyrotoxicosis, returns toward normal after treatment (21) . In none of these studies were values for the T4-binding capacity of TBPA or the per cent of free T4 after treatment reported. In the present studies, the only abnormality similar to that present during thyrotoxicosis which could be detected after treatment was a persistent significant decrease in the T4-binding capacity of TBPA. This decrease was slight, however, compared to that present before treatment. The T4-binding capacity of TBPA averaged 232 + 27 ug/100 ml in normal specimens and 199 + 29 jug/100 ml in sera from patients with treated thyrotoxicosis. As indicated earlier, this slight lowering of TBPA would not be expected to influence the overall binding of T4 appreciably, especially in the presence of a normal PBI and TBG (2, 27) . The lowering of TBG found during active thyrotoxicosis was completely reversed by treatment; indeed, T4-binding capacities of TBG were slightly, though not significantly, higher than normal in the serum of patients with treated thyrotoxicosis. This finding may account for the very slight lowering of the per cent of free T4 found in this group as compared to the normal controls. In all other respects, including PBI, absolute concentration of free T4, per cent of labeled T3 bound by TBG, and the response to T4 loading of both the per cent of free T4 and the binding of T3 by TBG, no difference between normal sera and those obtained after treatment of thyrotoxicosis was observed.
Despite some data which suggest the contrary (30), several studies indicate that abnormalities in the peripheral turnover of T4 persist at least in some patients with diffuse toxic goiter after relief of thyrotoxicosis. Lennon, Engbring, and Engstrom, who studied the early phase disappearance of T4 from plasma, i.e. that between 20 and 50 min after administration of the labeled hormone. found that the half-time of disappearance in hypothyroid patients after treatment was significantly faster than in patients with spontaneous myxedema. Furthermore, in patients rendered euthyroid by treatment, the half-time of early disappearance was significantly faster than in normal controls, although only marginally so (P < 0.05) (19) . Nicoloff and Dowling have reported in abstract form that both the early rate of disappearance of T4 and its early hepatic uptake are increased in patients with treated diffuse toxic goiter (20) . Examination of their data reveals the early (3 hr) hepatic uptake of T4 to be 40% higher than normal, and 3 hr deiodination rate 33% greater than normal, in patients euthyroid after treatment. 4 As regards the late phase metabolism of T4. i.e. that which occurs after distribution equilibrium, Ingbar and Freinkel have noted (17) a persistent increase in the fractional rate of T4 turnover in some patients with diffuse toxic goiter long after restoration of a euthyroid state. These data are in accord with those of Nicolof and Dowling,4 which demonstrate an increase of approximately 45% in mean daily T4 disposal and an increase in mean hepatic T4 content of more than 100%o in patients with Graves' disease rendered euthyroid. Although the studies of Sterling were taken to indicate that no abnormality of T4 turnover persists after treatment of thyrotoxicosis (30) , several aspects of the data in that publication suggest that many of the patients were mildly hypothyroid. Since hypothyroidism may itself retard the turnover of T4 (30, 31) , a persistent acceleration of turnover associated with Graves' disease may have been obscured.
Since none of the foregoing studies included measurements of T4 binding by techniques currently employed, it is pertinent to note that in a group of four patients studied in the author's laboratory before and approximately 6 months after treatment of thyrotoxicosis, normal values for the T4-binding capacity of TBG and TBPA were found after treatment, whereas the average half-time of T4 remained less than 4 days. 5 From all of the foregoing evidence, it may be concluded that abnormalities of T4 metabolism frequently, if not invariably, persist after relief of thyrotoxicosis in Graves' disease. It has generally been agreed that the proportion of free T4 in plasma is a major determinant of its fractional rate of turnover, and that the concentration of free T4 is a major determinant of total T4 disposal. crease in the proportion or concentration of free T4 in the serum of patients with treated thyrotoxicosis suggests that persistent abnormalities in T4 turnover do not result from disturbances in extracellular hormonal binding. Rather, they appear to result from factors within one or more cellular sites, such as the liver, where T4 is bound and metabolized (20, 32, 33) . The concept that cellular factors, in addition to extracellular binding, act as important determinants of the overall metabolism of T4 has been recognized for a considerable period (9, 11, 17, 18) , but has only recently been verified by direct evidence (34) .
Other instances of altered T4 turnover without evidence of abnormal extracellular binding are to be found in the progressive slowing of fractional T4 turnover that occurs with advancing age (28, 35) , and in the accelerated fractional turnover of T4 produced by thyroid-suppressive doses of T, (36) . Whether altered cellular metabolism of T4 in these and possibly other conditions arises from changes in the cellular binding of the hormone or in the enzymatic mechanisms for hormonal degradation or excretion is as yet unknown.
